Basic Research in Cardiology

, Volume 85, Issue 4, pp 392–403 | Cite as

Determinants of infarct size in non-human primates

  • W. Flameng
  • E. Lesaffre
  • J. Vanhaecke
Original Contributions


To achieve a better understanding of the major factors that determine infarct size in non-human primates, a mathematical model was constructed using stepwise regression analysis. The model was developed on the basis of infarct size measurements, including the anatomical area at risk, regional myocardial blood flow measurements and hemodynamic determinants obtained in 23 control baboons undergoing up to 2 h of coronary artery thrombosis followed by thrombolysis.

In this model, the size of the perfusion bed of the occluded coronary artery and the duration of coronary artery occlusion were found to be the only important predictors of infarct size (expressed as a percentage of left ventricular mass). R2 (square or the multiple correlation coefficient) was 70% in this model. Collateral blood flow and rate-pressure product were not identified as important predictors of infarct size.

In a second group of eight baboons, atenolol (0.1 mg·kg−1) was administered intravenously 15 min after the onset of coronary artery thrombosis. Predicted infarct size (based on the mathematical model obtained in the control group) was larger than the observed infarct size in seven out of eight cases. In four instances observed infarct size was smaller than the 95% lower limit of the predicted value.

It is concluded that the determinants of infarct size in non-human primates differ from those in canine models with respect to collateral flow and estimates of myocardial oxygen consumption (rate pressure product). The developed mathematical model of infarct size prediction allows the detection of cardioprotective drug effects with an acceptable efficacy.

Key words

infarct size baboons mathematical model coronary collateral flow 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Baroldi G (1966) Myocardial infarct and sudden coronary heart death in relation to coronary occlusion and collateral circulation. Am Heart J 71:826–836PubMedGoogle Scholar
  2. 2.
    Bush LR, Romson JL, Ash JL, Lucchesi BR (1982) Effects of diltiazem on extent of ultimate myocardial injury resulting from temporary coronary artery occlusion in dogs. J Cardiovasc Pharmacol 4:285–291PubMedGoogle Scholar
  3. 3.
    Buss Dd, Hyde DM, Stefey EP (1983) Coronary collateral development in the rhesus monkey (Macaca mulatta). Basic Res Cardiol 78:510–517PubMedGoogle Scholar
  4. 4.
    Cohen MV (1986) Coronary collaterals. Clinical and Experimental Observations. Futura Publishing Co, Mount Kisko, New YorkGoogle Scholar
  5. 5.
    Crozatier B, Rocs J Jr, Franklin D, Bloor C (1978) Myocardial infarction in the baboon: Regional function and the collateral circulation. Am J Physiol 235:H413–H421PubMedGoogle Scholar
  6. 6.
    Draper MR, Smith H (1981) Applied Regression Analysis, 2nd Edition. John Wiley & Sons, New YorkGoogle Scholar
  7. 7.
    Flameng W, Van de Werf F, Vanhaecke J, Verstraete M, Collen D (1985) Coronary thrombolysis and infarct size reduction after intravenous infusion of recombinant tissue-type plasminogen activator in nonhuman primates. J Clin Invest 75:84–90PubMedGoogle Scholar
  8. 8.
    Flameng W, Vanhaecke J, Vandeplassche G (1986) Studies on experimental myocardial infarction: dogs or baboons? Cardiovasc Res 20:241–247PubMedGoogle Scholar
  9. 9.
    Fox K, Welman E, Selwyn A (1980) Myocardial infarction in the dog: effects of intravenous propranolol. Am J Cardiol 45:769–774PubMedGoogle Scholar
  10. 10.
    Fulton WFM (1978) Intercoronary anastomoses studied by postmortem sterioarteriography: Relationship to coronary occlusion and myocardial damage. In: Kaltenbach M, Lichtlen P, Balcon R, Bussmann WD (eds) Coronary Heart Disease: 3rd International Symposium Frankfurt. Georg Thieme, Stuttgart, pp 2–11Google Scholar
  11. 11.
    Genth K, Hofmann M, Schaper W (1983) The effect of beta-adrenergic blockade on infarct size following experimental coronary occlusion. Basic Res Cardiol 76:144–141Google Scholar
  12. 12.
    Hammerman H, Kloner RA, Briggs LL, Braunwald E (1984) Enhancement of salvage of reperfused myocardium by early beta-adrenergic blockade blockade (timolol). J Am Cell Cardiol 3:1438–1443Google Scholar
  13. 13.
    ISIS-I (First International Study of Infarct Survival) Collaborative Group 1986. Randomized trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction. ISIS-I Lancet 2:57Google Scholar
  14. 14.
    Kato T (1976) A comparative study of the coronary arterial structure in the left ventricular free wall in infarcted and non-infarcted human hearts. Jpn Circ J 40:989–1003PubMedGoogle Scholar
  15. 15.
    Kloner RA, Fishbein MC, Braunwald E, Maroko PR (1978) Effect of propranolol on the mitochondrial morphology during acute myocardial ischemia. Am J Cardiol 41:880–886PubMedGoogle Scholar
  16. 16.
    Lange R, Nieminen MS, Kloner RA (1984) Failure of pindolol and metoprolol to reduce the size of non-reperfused infarcts in dogs using area at risk techniques. Cardiovasc Res 18:37–43PubMedGoogle Scholar
  17. 17.
    La Vallee W, Vatner F (1984) Regional myocardial blood flow and necrosis in primates following coronary occlusion. Am J Physiol 246:H635–H639PubMedGoogle Scholar
  18. 18.
    Lubbe WF, Peisach M, Pretorius R, Bruyneel K (1974) Distribution of myocardial blood flow before and after coronary artery ligation in the baboon. Relation to early ventricular fibrillation. Cardiovasc Res 478–487Google Scholar
  19. 19.
    Miura M, Thomas R, Ganz W, Sokol T, Shell WE, Toshimitsu T, Kwan AC, Singh BN (1979) The effect of delay in propranolol administration on reduction of myocardial infarct size after experimental coronary artery occlusion in dogs. Circ 59:1148–1157Google Scholar
  20. 20.
    Rasmussen MM, Reimer KA, Kloner RA, Jennings RB (1977) Infarct size reduction by propranolol before and after coronary ligation dogs. Circ 56:794–798PubMedGoogle Scholar
  21. 21.
    Reimer KA, Jennings RB (1979) The “Wavefront phenomenas” of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 40:633–644PubMedGoogle Scholar
  22. 22.
    Reimer KA, Jennings RB, Lobb FR, Murdock RH, Greenfield JC Jr, Becker LC, Healy Bulkey B, Hutchins GM, Schwartz RP Jr, Barley KR, Passamani ER (1985) Animal models for protecting ischemic myocardium: results of the NHLBI cooperative study. Circ Res 56:651–665PubMedGoogle Scholar
  23. 23.
    Reimer KA, Lowe J, Jennings RB (1977) Effects of the calcium antagonist verapamil on necrosis following temporary coronary artery occlusion in dogs. Circ 55:581PubMedGoogle Scholar
  24. 24.
    Reimer KA, Rasmussen MM, Jennings RB (1973) Reduction by propranolol of myocardial necrosis following temporary coronary artery occlusion in dogs. Circ Res 33:353–363PubMedGoogle Scholar
  25. 25.
    Reimer KA, Rasmussen MM, Jennings RB (1976) On the nature of protection by propranolol against myocardial necrosis after temporary coronary occlusion in dogs. Am J Cardiol 37:520–527PubMedGoogle Scholar
  26. 26.
    SAS User's Guide (1985) Statistics, Version 5. SAS Institute Inc, North CarolinaGoogle Scholar
  27. 27.
    Schaper W (1971a) Pathophysiology of coronary circulation. Prog Cardiovasc Res 14:275–296Google Scholar
  28. 28.
    Schaper W (1971b) The collateral circulation of the heart. North-Holland Publishing Co, AmsterdamGoogle Scholar
  29. 29.
    Schaper W, Flameng W, De Brabander M (1972) Comparative aspects of coronary collateral circulation. In: Bloor CM (ed) Comparative Pathophysiology of Circulatory Disturbances: Advances in Experimental Medicine and Biology, Vol 22. Plenum Press, New York, pp 267–276Google Scholar
  30. 30.
    Selpeskog EL, Hitchcock CR, Groover ME (1972) Coronary artery studies in the dog and Kenya baboon utilizing surgically induced myocardial infarctions. In: Vogtberg (ed) The Babbon in Medical Research. Univ of Texas Press, Austin, pp 557–566Google Scholar
  31. 31.
    Shatney CH, MacCarter DJ, Lillekei RC (1976) Effects of allopurinol, propranolol and methylprednisolone on infarct size in experimental myocardial infarction. Am J Cardiol 37:572–580PubMedGoogle Scholar
  32. 32.
    The Norwegian Multicenter Study Group (1981) Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 304:801–807Google Scholar
  33. 33.
    Van de Werf F, Vanhaccke J, Jang IK, Flameng W, Collen D, De Geest H (1987) Reduction in infarct size and enhanced recovery of systolic function after coronary thrombolysis with tissue-type plasminogen activator combined with beta-adrenergic blockade with metoprolol. Circ 75:830–836Google Scholar
  34. 34.
    Weisse AB, Kearny K, Narang RM, Regars J (1976) Comparison of the coronary collateral circulation in dogs and baboons after coronary occlusion. Am Heart J 92:193–200PubMedGoogle Scholar
  35. 35.
    Wüsten B, Flameng W, Schaper W (1974) The distribution of myocardial flow. Part I: Effects of experimental coronary occlusion. Basic Res Cardiol 69:422–434PubMedGoogle Scholar

Copyright information

© Dr. Dietrich Steinkopff Verlag 1990

Authors and Affiliations

  • W. Flameng
    • 1
  • E. Lesaffre
    • 1
  • J. Vanhaecke
    • 2
  1. 1.Department of Experimental Cardiac SurgeryCatholic University LeuvenLeuvenBelgium
  2. 2.Department of CardiologyCatholic University LeuvenLeuvenBelgium

Personalised recommendations